Beyond HIV prevention: Assessment of the benefits of pre-exposure prophylaxis for sexual quality of life
Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
SAGE PUBLICATIONS LTD
Citação
INTERNATIONAL JOURNAL OF STD & AIDS, v.35, n.1, p.48-57, 2024
Resumo
Background: Pre-exposure prophylaxis (PrEP) may favor sexual satisfaction by reducing the fear of HIV and promoting less restrictive sexual practices. These benefits may be even higher among PrEP users with mental health issues. Methods: We invited adult PrEP users to answer a questionnaire including demographics, questions on the sexual experience compared to the period before PrEP use, and the Hospital Anxiety and Depression Scale. Factors associated with improvements in the sexual experience were investigated using modified Poisson models. Results: We included 221 participants; most were white males. A large percentage of participants reported improvements in quality of sex after PrEP initiation; the composite outcome ""PrEP-associated improvement in the quality of sex"" was observed in 92 (42%), whereas the outcome ""PrEP-associated improvement in the fear of HIV acquisition"" was observed in 120 participants (54%). Demographics and depression/anxiety were not significantly associated with the outcomes. Conclusion: PrEP has positive effects beyond HIV prevention, improving several aspects of sexual quality of life. These benefits are valid incentives for PrEP use and prescription.
Palavras-chave
Pre-exposure prophylaxis, prevention, HIV, sexuality, sexual quality of life
Referências
- Brasil. Ministerio da Saude, 2018, PROT CLIN DIR TER PR, V52
- Calabrese SK, 2020, CURR HIV-AIDS REP, V17, P579, DOI 10.1007/s11904-020-00533-y
- Calabrese SK, 2015, AM J PUBLIC HEALTH, V105, P1960, DOI 10.2105/AJPH.2015.302816
- Castro DR, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25351
- Cerqueira NB, 2020, AIDS RES HUM RETROV, V36, P1047, DOI [10.1089/aid.2019.0281, 10.1089/AID.2019.0281]
- Costa AB, 2022, AIDS CARE, V34, P16, DOI 10.1080/09540121.2021.1876836
- Curley CM, 2022, J SEX RES, V59, P848, DOI 10.1080/00224499.2021.2012638
- Gamarel KE, 2015, ANN BEHAV MED, V49, P177, DOI 10.1007/s12160-014-9646-3
- Golub SA, 2012, AIDS BEHAV, V16, P626, DOI 10.1007/s10461-011-9972-4
- Jenness SM, 2017, CLIN INFECT DIS, V65, P712, DOI 10.1093/cid/cix439
- Keen P, 2020, JAIDS-J ACQ IMM DEF, V83, P119, DOI 10.1097/QAI.0000000000002232
- Kumar S, 2021, AIDS BEHAV, V25, P1810, DOI 10.1007/s10461-020-03110-x
- Mabire X, 2019, AM J MENS HEALTH, V13, DOI 10.1177/1557988319827396
- Manguro GO, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-022-12639-6
- McGahuey CA, 2000, J SEX MARITAL THER, V26, P25, DOI 10.1080/009262300278623
- Mehta SD, 2021, AIDS BEHAV, V25, P2219, DOI 10.1007/s10461-020-03150-3
- Painel PrEP, 2022, DEP DOENC COND CRON
- Segal K., 2021, EVOLUTION ORAL PREP
- Sullivan PS, 2022, CURR OPIN INFECT DIS, V35, P1, DOI 10.1097/QCO.0000000000000809
- Traeger MW, 2019, JAMA-J AM MED ASSOC, V321, P1380, DOI 10.1001/jama.2019.2947
- UNAIDS, 2022, In Danger: UNAIDS Global AIDS Update 2022
- Van Dijk M, 2022, J SEX RES, V59, P303, DOI 10.1080/00224499.2021.1931653
- ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x